Cargando…

Editorial: Immune Cell Lineage Reprogramming in Cancer

Detalles Bibliográficos
Autores principales:	Leavenworth, Jianmei W., Shi, Lewis Zhichang, Wang, Xi, Wei, Haiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807485/ https://www.ncbi.nlm.nih.gov/pubmed/35126385 http://dx.doi.org/10.3389/fimmu.2021.838464

Ejemplares similares

Lineage Reprogramming of Effector Regulatory T Cells in Cancer
por: Dixon, Michael L., et al.
Publicado: (2021)

Editorial: Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies
por: Leavenworth, Jianmei W., et al.
Publicado: (2022)

Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies
por: Leavenworth, Jianmei W., et al.
Publicado: (2022)

Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis
por: Seals, Malik R., et al.
Publicado: (2022)

Editorial: Ionizing radiation reprograms tumor immune microenvironment by inducing immunogenic cell death
por: Yu, Fei, et al.
Publicado: (2023)

Editorial: Lineage tracing, hematopoietic stem cell and immune cell dynamics
por: Lareau, Caleb A., et al.
Publicado: (2022)

Editorial: Nanoparticle-Mediated Signaling Rewiring and Reprogramming of Immune Responses
por: Quintana, Francisco J., et al.
Publicado: (2022)

Innate immunity in pancreatic cancer: Lineage tracing and function
por: Ye, Longyun, et al.
Publicado: (2023)

Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma
por: Won, Woong-Jai, et al.
Publicado: (2019)

Understanding and Modulating Immunity With Cell Reprogramming
por: Pires, Cristiana F., et al.
Publicado: (2019)

Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
por: Dong, Yan, et al.
Publicado: (2021)

Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer
por: Huang, Maosen, et al.
Publicado: (2023)

Metabolic Reprogramming and Reactive Oxygen Species in T Cell Immunity
por: Peng, Hao-Yun, et al.
Publicado: (2021)

Editorial: The Role of Biomembranes and Biophysics in Immune Cell Signaling
por: Shi, Yan, et al.
Publicado: (2021)

Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease
por: Li, He, et al.
Publicado: (2021)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
por: Yin, Jie, et al.
Publicado: (2017)

Editorial: The role of hematopoietic and immune microenvironment in hematopoietic stem cell transplantation
por: Wang, Xiaoqi, et al.
Publicado: (2023)

AIMing 2 promote lupus by targeting helpers
por: Leavenworth, Jianmei W.
Publicado: (2022)

Editorial: Innate immune cell therapy of cancer
por: Khatwani, Natasha, et al.
Publicado: (2022)

Metabolic Reprogramming of Immune Cells at the Maternal-Fetal Interface and the Development of Techniques for Immunometabolism
por: Wei, Yiqiu, et al.
Publicado: (2021)

Editorial: Endothelial cells as innate immune cells
por: Lu, Yifan, et al.
Publicado: (2022)

Similarities in the Metabolic Reprogramming of Immune System and Endothelium
por: Tang, Chu-Yik, et al.
Publicado: (2017)

Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma
por: Huang, Huimei, et al.
Publicado: (2021)

Editorial: Tumor-promoting immune cells: Cancer immune escape and beyond
por: Domblides, Charlotte, et al.
Publicado: (2023)

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022)

Editorial: Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment
por: Li, Yongsheng, et al.
Publicado: (2018)

Editorial: Immune Cells in the Mucosa
por: Pandiyan, Pushpa, et al.
Publicado: (2016)

Cell Fate Reprogramming in the Era of Cancer Immunotherapy
por: Zimmermannova, Olga, et al.
Publicado: (2021)

Editorial: Regulation of Immunity by Non-Immune Cells
por: Dainichi, Teruki, et al.
Publicado: (2021)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response
por: Basit, Farhan, et al.
Publicado: (2018)

Editorial: Regulatory T lymphocytes in cancer immunity
por: Adeegbe, Dennis, et al.
Publicado: (2022)

Editorial: Calcium signaling in cancer immunity
por: Amantini, Consuelo, et al.
Publicado: (2023)

Editorial: Sustained Effects of Early Nutrition on Immune Development and Microbiome-Immune Crosstalk
por: Lewis, Marie C., et al.
Publicado: (2020)

Editorial: Wnt Signaling in Immune Cell Regulation During Microbial Infection and Cancer
por: Blumenthal, Antje, et al.
Publicado: (2020)

Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
por: Lin, Yi, et al.
Publicado: (2022)

RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4(+) T-cell-dependent antitumor immunity
por: Zhang, Zhuo, et al.
Publicado: (2021)

Editorial: The role of immune cells in hepatic ischemia reperfusion
por: Ke, Bibo, et al.
Publicado: (2022)

Editorial: Immunomodulation of Innate Immune Cells
por: Almeida, Catarina R., et al.
Publicado: (2020)

Editorial: Immune Modulation by Flavonoids
por: Hoskin, David W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hdfr29m4df7v5l5fgtuh18mncg